ATI RN
Pharmacology of CNS Drugs Questions
Question 1 of 5
A 55-year-old woman is noted to be taking tamoxifen to help with breast cancer. She also complains of vaginal bleeding. She asks why she is having vaginal bleeding. Which of the following is the best explanation?
Correct Answer: C
Rationale: Tamoxifen (choice C), a SERM, acts as an estrogen antagonist in breast tissue, inhibiting cancer growth, but as an agonist in the uterus, stimulating endometrial proliferation, which can cause vaginal bleeding due to hyperplasia. Choice A incorrectly suggests agonism in the breast, choice B misstates uterine antagonism, and choice D ignores its uterine effect. This tissue-selective action explains the bleeding, a known side effect requiring monitoring, as it increases endometrial cancer risk. Understanding tamoxifen's dual role is critical for managing breast cancer patients, balancing therapeutic benefits against uterine complications.
Question 2 of 5
Which of the following drugs is contraindicated in a patient with porphyria?
Correct Answer: D
Rationale: In this case, the correct answer is D) Phenobarbitone. Porphyria is a group of disorders characterized by an abnormal accumulation of porphyrins in the body, which can lead to symptoms like abdominal pain, neurological issues, and skin sensitivity to light. Phenobarbitone is contraindicated in patients with porphyria because it can trigger acute attacks due to its enzyme-inducing properties, leading to an exacerbation of symptoms. Now, let's discuss why the other options are incorrect: A) Zolpidem is a sedative-hypnotic primarily used for insomnia and is not known to exacerbate porphyria. B) Chloral hydrate is a sedative and hypnotic agent, but it is not typically associated with porphyria exacerbation. C) Buspirone is an anxiolytic medication that does not have known contraindications specifically related to porphyria. From an educational standpoint, understanding the contraindications of drugs in specific patient populations is crucial for safe prescribing practices. It highlights the importance of thorough patient assessments, including medical history, to avoid adverse drug reactions and complications. Students and healthcare professionals should be aware of such contraindications to provide optimal care and prevent harm to patients with specific conditions like porphyria.
Question 3 of 5
Which of the following local anaesthetic agents is an ester?
Correct Answer: D
Rationale: In pharmacology, understanding the classification of local anesthetic agents is crucial for safe and effective clinical practice. In this question, the correct answer is D) Procaine because it is an ester-type local anesthetic. Procaine is a short-acting local anesthetic that is hydrolyzed by plasma esterases. Option A, Bupivacaine, and option B, Ropivacaine, are both amide-type local anesthetics. These drugs are metabolized in the liver via the cytochrome P450 system, making them longer-acting compared to ester-type local anesthetics. Option C, Prilocaine, is an amide-type local anesthetic as well. It is metabolized in the liver and lungs. Educationally, understanding the differentiation between ester and amide local anesthetics is important for pharmacology students and healthcare professionals. Ester-type local anesthetics like procaine are more likely to cause allergic reactions due to the formation of para-aminobenzoic acid (PABA) as a metabolite. This knowledge is crucial for selecting the appropriate local anesthetic based on patient history and potential allergies.
Question 4 of 5
Which of the following statements about local anesthetic agents is correct?
Correct Answer: D
Rationale: The correct answer is D) Activity is enhanced by high extracellular K+ concentration. Local anesthetic agents work by blocking voltage-gated Na+ channels, preventing the influx of sodium ions and thus inhibiting the initiation and conduction of action potentials in neurons. High extracellular K+ concentration enhances the activity of local anesthetics by promoting a greater influx of the drug into the neuron through the concentration gradient. This phenomenon is known as the "ion trapping" effect, where the local anesthetic agent is more likely to exist in its lipid-soluble, active form in the presence of high extracellular K+. Option A is incorrect because local anesthetic agents primarily target Na+ channels rather than K+ channels. Option B is incorrect because local anesthetics actually prevent depolarization, not repolarization, by inhibiting the influx of sodium ions. Option C is incorrect because while vasodilators can improve the diffusion of local anesthetics in tissues, they do not directly prolong the local action of the anesthetic agent. Understanding the pharmacology of CNS drugs, including local anesthetics, is crucial for healthcare professionals such as nurses, pharmacists, and physicians. Knowing how these drugs work at the molecular level can help in their safe and effective administration, as well as in understanding potential drug interactions and side effects. This knowledge is essential for providing quality patient care and ensuring positive treatment outcomes.
Question 5 of 5
Commonalities of the sympathetic, parasympathetic, and somatic nervous systems involve which of the following neuroeffector transmitters?
Correct Answer: A
Rationale: The correct answer is A) Acetylcholine. Acetylcholine is the neurotransmitter common to the sympathetic, parasympathetic, and somatic nervous systems. This neurotransmitter is released at the neuroeffector junctions of the parasympathetic and sympathetic nervous systems as well as at the neuromuscular junction in the somatic nervous system. Dopamine (option B) is a neurotransmitter predominantly found in the central nervous system and is not a primary neuroeffector transmitter in the autonomic or somatic nervous systems. Epinephrine (option C) and norepinephrine (option D) are primarily neurotransmitters of the sympathetic nervous system, released by postganglionic neurons. While they play important roles in the sympathetic response, they are not shared across all three systems. Understanding the commonalities and differences in neuroeffector transmitters among the sympathetic, parasympathetic, and somatic nervous systems is crucial in pharmacology to target specific pathways for therapeutic interventions and minimize side effects. Acetylcholine's widespread role highlights its significance in mediating various physiological responses in the body.